🕵️ Ardent Health, Inc. ($ARDT)
SEC insider & ownership activity, last 12 months · CIK 1756655 · every row links its SEC filing
Over the last 12 months insiders bought $186K with no open-market selling against it. Demichiei Robert bought $98K in discretionary trades (Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $186K (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Demichiei Robert | 1 | $98K | 0 | – | Jun 5, 2026 |
| Lumsdaine Alfred | 1 | $88K | 0 | – | Jun 5, 2026 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Bonick Martin | $398K | Aug 27, 2026 | filing ↗ |
| Bonick Martin | $401K | Aug 25, 2026 | filing ↗ |
| Bonick Martin | $377K | Aug 20, 2026 | filing ↗ |
| Bonick Martin | $393K | Aug 18, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Sep 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2026 | filing ↗ |
| Earnings (2.02) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 24, 2026 | filing ↗ |
| Earnings (2.02) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 17, 2025 | filing ↗ |
| Other events (8.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 18, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 18, 2025 | filing ↗ |